SEC Company Response from Fresh2 Group Ltd (FRES) (CIK 0001786511) — Jan 24, 2020
Fresh2 Group Ltd (FRES) (CIK 0001786511)
Date: Jan. 24, 2020 · CIK: 0001786511 · Accession: 0001193125-20-013497
AI Filing Summary & Sentiment
File numbers found in text: 333-234408
Letter
WestPark Capital, Inc.
Suite 310, 1900 Avenue of the Stars
Los Angeles, CA 90067
United States of America
Univest Securities, LLC
15th Floor, 375 Park Avenue
New York, NY 10152
United States of America
As representatives of the several underwriters
VIA EDGAR
January 24, 2020
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention:
Angela Lumley
Rufus Decker
Jonathan Burr
Brigitte Lippmann
Re:
AnPac Bio-Medical Science Co., Ltd. (the “Company”)
Registration Statement on Form F-1 (File No. 333-234408)
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), we, as representatives of the several underwriters of the Company’s proposed initial public offering, hereby join the Company’s request that the effective date of the above-referenced Registration Statement be accelerated so that the above-referenced Registration Statement will be declared effective at 4:00 p.m., Eastern Time, on January 28, 2020, or as soon thereafter as is practicable.
Pursuant to Rule 460 of the Securities Act, we wish to advise you that we have effected the following distribution of the Company’s Preliminary Prospectus, dated December 11, 2019, through the date hereof:
Preliminary Prospectus dated December 11, 2019:
500 copies to prospective underwriters, institutional investors, dealers and others
The undersigned advise that they have complied and will continue to comply, and that they have been informed by the participating underwriters and dealers that they have complied with and will continue to comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
[Remainder of Page Intentionally Left Blank]
Very truly yours,
By WESTPARK CAPITAL, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP WestPark Capital, Inc. Suite 310, 1900 Avenue of the Stars Los Angeles, CA 90067 United States of America Univest Securities, LLC 15th Floor, 375 Park Avenue New York, NY 10152 United States of America As representatives of the several underwriters VIA EDGAR January 24, 2020 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Angela Lumley Rufus Decker Jonathan Burr Brigitte Lippmann Re: AnPac Bio-Medical Science Co., Ltd. (the “Company”) Registration Statement on Form F-1 (File No. 333-234408) Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), we, as representatives of the several underwriters of the Company’s proposed initial public offering, hereby join the Company’s request that the effective date of the above-referenced Registration Statement be accelerated so that the above-referenced Registration Statement will be declared effective at 4:00 p.m., Eastern Time, on January 28, 2020, or as soon thereafter as is practicable. Pursuant to Rule 460 of the Securities Act, we wish to advise you that we have effected the following distribution of the Company’s Preliminary Prospectus, dated December 11, 2019, through the date hereof: Preliminary Prospectus dated December 11, 2019: 500 copies to prospective underwriters, institutional investors, dealers and others The undersigned advise that they have complied and will continue to comply, and that they have been informed by the participating underwriters and dealers that they have complied with and will continue to comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. [Remainder of Page Intentionally Left Blank] Very truly yours, By WESTPARK CAPITAL, INC. By: /s/ Craig Kaufman Authorized Representative By UNIVEST SECURITIES LLC By: /s/ Edric Guo Authorized Representative Acting on behalf of themselves and as the Representatives of the several Underwriters